United States · FDA National Drug Code directory
Sodium Nitroprusside
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 14335-134_e826d769-c243-f0ac-e053-2995a90afcff
- Product NDC
- 14335-134
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Sodium Nitroprusside
- Labeler
- Hainan Poly Pharm. Co., Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221231
- Source listing expiry
- 20261231
Source-listed ingredients
- SODIUM NITROPRUSSIDE — .5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (14335-134-01) / 100 mL in 1 VIAL · 14335-134-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →